Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NUVB |
---|---|---|
09:32 ET | 12101 | 3.76 |
09:36 ET | 700 | 3.74 |
09:38 ET | 1900 | 3.765 |
09:39 ET | 3524 | 3.72 |
09:41 ET | 8561 | 3.7492 |
09:43 ET | 10129 | 3.77 |
09:45 ET | 2080 | 3.7738 |
09:48 ET | 5759 | 3.788 |
09:50 ET | 33376 | 3.81 |
09:52 ET | 11998 | 3.81 |
09:54 ET | 4539 | 3.7983 |
09:56 ET | 9102 | 3.8199 |
09:57 ET | 1300 | 3.81 |
09:59 ET | 3311 | 3.8097 |
10:01 ET | 4469 | 3.8197 |
10:03 ET | 11008 | 3.805 |
10:06 ET | 2459 | 3.805 |
10:08 ET | 5796 | 3.8 |
10:10 ET | 3042 | 3.785 |
10:12 ET | 4481 | 3.805 |
10:14 ET | 5471 | 3.795 |
10:15 ET | 4517 | 3.775 |
10:17 ET | 326 | 3.775 |
10:19 ET | 1344 | 3.76 |
10:21 ET | 2639 | 3.75 |
10:24 ET | 4104 | 3.74 |
10:26 ET | 4679 | 3.745 |
10:30 ET | 3934 | 3.72 |
10:32 ET | 7441 | 3.705 |
10:33 ET | 1601 | 3.7 |
10:35 ET | 5657 | 3.6999 |
10:37 ET | 3123 | 3.7 |
10:39 ET | 640 | 3.7 |
10:42 ET | 8240 | 3.735 |
10:44 ET | 6490 | 3.75 |
10:46 ET | 8295 | 3.75 |
10:48 ET | 3040 | 3.75 |
10:50 ET | 3510 | 3.76 |
10:51 ET | 1300 | 3.74 |
10:53 ET | 990 | 3.745 |
10:55 ET | 4084 | 3.745 |
10:57 ET | 720 | 3.76 |
11:00 ET | 158 | 3.765 |
11:02 ET | 1048 | 3.765 |
11:04 ET | 7416 | 3.76 |
11:06 ET | 400 | 3.765 |
11:08 ET | 3330 | 3.75 |
11:09 ET | 2072 | 3.745 |
11:13 ET | 2336 | 3.745 |
11:15 ET | 2086 | 3.73 |
11:18 ET | 100 | 3.725 |
11:20 ET | 4865 | 3.725 |
11:22 ET | 1600 | 3.725 |
11:26 ET | 4871 | 3.725 |
11:31 ET | 1470 | 3.74 |
11:33 ET | 2153 | 3.7264 |
11:36 ET | 1084 | 3.72 |
11:38 ET | 2500 | 3.72 |
11:40 ET | 1588 | 3.73 |
11:42 ET | 1000 | 3.73 |
11:44 ET | 724 | 3.73 |
11:45 ET | 2046 | 3.735 |
11:47 ET | 5878 | 3.715 |
11:49 ET | 1097 | 3.715 |
11:54 ET | 4384 | 3.72 |
11:56 ET | 5231 | 3.7078 |
11:58 ET | 12175 | 3.68 |
12:00 ET | 3293 | 3.69 |
12:02 ET | 41338 | 3.71 |
12:03 ET | 4845 | 3.7 |
12:05 ET | 7500 | 3.68 |
12:07 ET | 350 | 3.685 |
12:09 ET | 7795 | 3.695 |
12:12 ET | 5215 | 3.6899 |
12:14 ET | 2100 | 3.67 |
12:16 ET | 448 | 3.665 |
12:18 ET | 1206 | 3.6608 |
12:20 ET | 3660 | 3.6601 |
12:21 ET | 5596 | 3.665 |
12:23 ET | 7033 | 3.66 |
12:25 ET | 900 | 3.66 |
12:27 ET | 1087 | 3.66 |
12:30 ET | 800 | 3.66 |
12:32 ET | 2184 | 3.66 |
12:34 ET | 2932 | 3.66 |
12:36 ET | 1330 | 3.65 |
12:38 ET | 18329 | 3.64 |
12:39 ET | 9895 | 3.655 |
12:41 ET | 2097 | 3.665 |
12:43 ET | 2232 | 3.68 |
12:45 ET | 4220 | 3.68 |
12:50 ET | 4022 | 3.665 |
12:52 ET | 500 | 3.665 |
12:54 ET | 443 | 3.67 |
12:56 ET | 200 | 3.665 |
12:57 ET | 583 | 3.665 |
12:59 ET | 500 | 3.66 |
01:01 ET | 700 | 3.66 |
01:03 ET | 4571 | 3.66 |
01:06 ET | 11516 | 3.695 |
01:08 ET | 5308 | 3.67 |
01:10 ET | 2000 | 3.675 |
01:12 ET | 600 | 3.675 |
01:15 ET | 1690 | 3.67 |
01:17 ET | 3473 | 3.66 |
01:19 ET | 2281 | 3.66 |
01:21 ET | 7491 | 3.66 |
01:24 ET | 300 | 3.666 |
01:26 ET | 400 | 3.665 |
01:28 ET | 100 | 3.665 |
01:30 ET | 5642 | 3.675 |
01:32 ET | 565 | 3.675 |
01:33 ET | 1072 | 3.67 |
01:35 ET | 19527 | 3.705 |
01:37 ET | 2011 | 3.715 |
01:39 ET | 700 | 3.71 |
01:42 ET | 4243 | 3.725 |
01:44 ET | 500 | 3.725 |
01:46 ET | 5447 | 3.735 |
01:48 ET | 7627 | 3.725 |
01:50 ET | 1690 | 3.71 |
01:53 ET | 236 | 3.705 |
01:57 ET | 6046 | 3.715 |
02:00 ET | 300 | 3.715 |
02:02 ET | 100 | 3.715 |
02:04 ET | 2991 | 3.73 |
02:06 ET | 430 | 3.72 |
02:08 ET | 4987 | 3.7201 |
02:11 ET | 50279 | 3.7 |
02:13 ET | 300 | 3.7 |
02:15 ET | 700 | 3.7 |
02:18 ET | 1143 | 3.7 |
02:20 ET | 8786 | 3.69 |
02:22 ET | 3282 | 3.69 |
02:24 ET | 1295 | 3.695 |
02:26 ET | 2400 | 3.69 |
02:27 ET | 1789 | 3.69 |
02:29 ET | 1400 | 3.695 |
02:31 ET | 1205 | 3.69 |
02:33 ET | 2249 | 3.69 |
02:36 ET | 2074 | 3.69 |
02:38 ET | 1441 | 3.695 |
02:40 ET | 9298 | 3.705 |
02:42 ET | 5221 | 3.685 |
02:47 ET | 3200 | 3.685 |
02:49 ET | 3220 | 3.68 |
02:51 ET | 400 | 3.6801 |
02:54 ET | 1400 | 3.685 |
02:56 ET | 500 | 3.68 |
02:58 ET | 3058 | 3.68 |
03:00 ET | 2605 | 3.67 |
03:02 ET | 800 | 3.67 |
03:03 ET | 600 | 3.67 |
03:05 ET | 1300 | 3.665 |
03:07 ET | 10635 | 3.675 |
03:09 ET | 400 | 3.675 |
03:12 ET | 400 | 3.68 |
03:14 ET | 2707 | 3.68 |
03:16 ET | 607 | 3.68 |
03:18 ET | 2200 | 3.685 |
03:20 ET | 11871 | 3.69 |
03:21 ET | 1716 | 3.695 |
03:23 ET | 1102 | 3.695 |
03:25 ET | 4998 | 3.705 |
03:27 ET | 14868 | 3.705 |
03:30 ET | 8730 | 3.715 |
03:32 ET | 1343 | 3.715 |
03:34 ET | 900 | 3.715 |
03:36 ET | 2626 | 3.715 |
03:38 ET | 2039 | 3.7101 |
03:39 ET | 10386 | 3.725 |
03:41 ET | 5338 | 3.725 |
03:43 ET | 2100 | 3.725 |
03:45 ET | 6950 | 3.74 |
03:48 ET | 3779 | 3.74 |
03:50 ET | 2720 | 3.735 |
03:52 ET | 47490 | 3.7425 |
03:54 ET | 22871 | 3.74 |
03:56 ET | 6799 | 3.74 |
03:57 ET | 12983 | 3.74 |
03:59 ET | 243675 | 3.74 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Nuvation Bio Inc | 912.1M | -11.9x | --- |
Perspective Therapeutics Inc | 917.7M | -8.4x | --- |
Cogent Biosciences Inc | 881.6M | -3.8x | --- |
89Bio Inc | 950.4M | -4.6x | --- |
Humacyte Inc | 970.5M | -7.9x | --- |
Lexicon Pharmaceuticals Inc | 842.2M | -2.9x | --- |
Nuvation Bio Inc. is a biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. The Company is advancing multiple clinical-stage candidates, including a ROS1 inhibitor, a mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor, a bromodomain and extra-terminal (BET) inhibitor, and a drug-drug conjugate (DDC). Its portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Taletrectinib is an oral, potent, CNS-active, selective, ROS1 inhibitor specifically designed for the potential treatment of ROS1-positive non-small cell lung cancer (NSCLC). Safusidenib is an oral, potent, targeted inhibitor of mIDH1 being evaluated in a global Phase II trial in patients with low-grade IDH1-mutant glioma. NUV-868 is a BD2-selective oral small molecule BET inhibitor, that inhibits BRD4. It is conducting Phase I/II study of NUV-1511.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $912.1M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 247.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.34 |
EPS | $-0.31 |
Book Value | $2.76 |
P/E Ratio | -11.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.